274 Novartis Investigational Site — Park City, Kansas

274 Novartis Investigational Site is a clinical research site located in Park City, Kansas, United States 67219.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

274 Novartis Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Park City

Browse all research sites in Kansas · View every site in Park City

• Novo Nordisk Investigational Site
• Heartland Research Associates LLC
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 274 Novartis Investigational Site?

274 Novartis Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 274 Novartis Investigational Site conducted?

274 Novartis Investigational Site has 1 clinical trials on record. Their work covers Influenza Virus.

Is 274 Novartis Investigational Site accredited by Crixeo Clinical Trials?

274 Novartis Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 274 Novartis Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.